Delivery Order SPE2DB25D3012-SPE2DB25FWZDR
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on November 5, 2025, with completion targeted for November 28, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on December 11, 2025, with a completion date of January 5, 2026. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,814.08 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a Delivery Order valued at $4,542.74 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count packages) with a completion date of October 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a firm fixed price of $2,271.36 and an ultimate completion date of October 16, 2025. This is a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yonsa 125 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract. The delivery order, valued at $2,393.67, was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count units). This contract, issued on March 18, 2025, with an ultimate completion date of April 8, 2025, operates under a firm fixed-price structure with no set-aside designation. The award represents a competitive procurement action, reflecting the vendor's established capability to meet federal pharmaceutical supply requirements....
- The Defense Logistics Agency awarded a delivery order valued at $45,427.20 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120 count) with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a ceiling value of $4,542.74. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZDRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for the supply of Yonsa 125 mg tablets (120-count) with an ultimate completion date of September 3, 2025. This non-set-aside contract employs firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor headquartered in Pennsylvania, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that supports comprehensive global pharmaceutical supply to military healthcare programs worldwide. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military medical supply operations. AmerisourceBergen Drug Corp's extensive federal contracting history demonstrates consistent capability in delivering specialized pharmaceuticals and medical supplies across multiple therapeutic domains through competitive procurement processes. The award reflects the company's role as a prime pharmaceutical vendor within DLA's strategic supply chain framework, which supports medical requirements for military personnel, veterans, and other authorized federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/12/25 |